Pines Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.11M Sell
5,004
-31
-0.6% -$12.4K 0.6% 37
2026
Q2
$1.82M Sell
5,035
-11
-0.2% -$3.76K 0.52% 46
2026
Q1
$1.78M Sell
5,046
-44
-0.9% -$15.7K 0.57% 37
2025
Q4
$1.67M Buy
5,090
+24
+0.5% +$7.61K 0.54% 44
2025
Q3
$1.43M Sell
5,066
-45
-0.9% -$13.1K 0.48% 50
2025
Q2
$1.52M Buy
5,111
+145
+3% +$41.1K 0.54% 41
2025
Q1
$1.39M Buy
4,966
+191
+4% +$56.4K 0.64% 36
2024
Q4
$1.25M Buy
+4,775
New +$1.42M 0.54% 44

Other funds holding AMGN

Pines Wealth Management's AMGN Position: Q3 2026 in Review

Pines Wealth Management reduced its Amgen (AMGN) stake by 0.62% in Q3 2026, selling an estimated $12.4K and leaving 5,004 shares worth $2.11M. The position accounts for 0.6% of the portfolio, ranked #37.

Pines Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Pines Wealth Management held 5,004 shares of Amgen worth $2.11M as of Q3 2026.
  • Pines Wealth Management sold 31 Amgen shares in Q3 2026, an estimated $12.4K.
  • Amgen made up 0.6% of Pines Wealth Management's portfolio in Q3 2026, its #37 holding.
  • Pines Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Pines Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.